港股異動丨智雲健康飆升27%,宣佈接入DeepSeek提升智雲大腦
繼昨日收升26.77%後,智雲健康(9955.HK)今日盤初再度飆升27.33%,報2.05港元,股價創2024年10月以來新高。公司宣佈,於2月將DeepSeek-R1模型接入其專屬醫療人工智能智雲大腦,進一步增強智雲大腦的數據挖掘能力,並提升公司醫院SaaS及藥店SaaS的慢病管理效率。公司表示,智雲大腦對DeepSeek-R1模型的接入,結合了先進的數據分析和人工智能技術,通過大數據分析及機器學習算法,為慢病管理提供精準的決策支持。此次接入後,藉助公司超過10億份電子病歷,公司的ClouD GPT及ClouD DTx模型將實現醫療知識圖譜和臨牀決策支持系統的功能升級,以優化用户體驗並提高診斷效率。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.